Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 477 participants.

Also called NCT04818645

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 477 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04818645
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04818645. Randomized; single masking; primary purpose prevention. Start 2023-01-31 (actual); primary completion 2028-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients
Acronym
ASSERT-AF
Condition
Heart Failure
Intervention (Device)
ASSERT Insertable Cardiac Monitor
Intervention (Other)
Conventional Management and monitoring
Lead sponsor
University of Rochester (class: other)
Collaborator
Abbott (class: industry)

Record details

Record id
cardio:ct-nct04818645
Content hash
8389757525f795e96711c8e2c4cb9489f7d03be0aaa857537c5c70a2e52e2026